The Kinase Inhibitor TKI258 Is Active Against the Novel CUX1-FGFR1 Fusion Detected in a Patient With T-Lymphoblastic Leukemia/Lymphoma and T(7;8)(q22;p11)

Haematologica- Italy

doi 10.3324/haematol.2010.036558

Full Text

Abstract

Available in

Categories

Hematology

Date

Authors

Publisher

Ferrata Storti Foundation (Haematologica)


Related search